Corey Edwards
Biographic Data
| ID | 7972129 |
|---|---|
| NAME | Corey Edwards |
| GIVEN NAMES | Corey |
| FAMILY NAME | Edwards |
| SIGNATURE | EDWARDS C |
| AFFILIATIONS | VA San Diego Healthcare System |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole
Antipsychotic drugs cause metabolic abnormalities through a mechanism that involves antagonism of D 2 dopamine receptors (D 2 R). Under healthy conditions, insulin release follows a circadian rhythm and is low at night, and in pancreatic beta-cells, D 2 Rs negatively regulate insulin release. Since they are sedating, many antipsychotics are dosed at night. However, the resulting reduction in overnight D 2 R activity may disrupt 24 h rhythms in in…
No prominent works on this page.
Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole
Antipsychotic drugs cause metabolic abnormalities through a mechanism that involves antagonism of D 2 dopamine receptors (D 2 R). Under healthy conditions, insulin release follows a circadian rhythm and is low at night, and in pancreatic beta-cells, D 2 Rs negatively regulate insulin release. Since they are sedating, many antipsychotics are dosed at night. However, the resulting reduction in overnight D 2 R activity may disrupt 24 h rhythms in in…
Aripiprazole (1 work) · Circadian rhythm and melatonin (1 work) · Drug (1 work) · Medicine (1 work) · Pharmacology (1 work) · Psychiatry (1 work) · Schizophrenia (object-oriented programming (1 work) · Schizophrenia research and treatment (1 work) · Sleep and related disorders (1 work)